These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 14991389)

  • 1. Bone histology in steroid-treated children with non-azotemic nephrotic syndrome.
    Freundlich M; Jofe M; Goodman WG; Salusky IB
    Pediatr Nephrol; 2004 Apr; 19(4):400-7. PubMed ID: 14991389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone histology in patients with nephrotic syndrome and normal renal function.
    Mittal SK; Dash SC; Tiwari SC; Agarwal SK; Saxena S; Fishbane S
    Kidney Int; 1999 May; 55(5):1912-9. PubMed ID: 10231454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteomalacia and hyperparathyroid bone disease in patients with nephrotic syndrome.
    Malluche HH; Goldstein DA; Massry SG
    J Clin Invest; 1979 Mar; 63(3):494-500. PubMed ID: 429568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three-monthly bolus vitamin D supplements (1000 vs 400 IU/day) for prevention of bone loss in children with difficult-to-treat nephrotic syndrome: a randomised clinical trial.
    Singh DN; Krishnamurthy S; Kamalanathan SK; Harichandrakumar KT; Sivamurukan P
    Paediatr Int Child Health; 2018 Nov; 38(4):251-260. PubMed ID: 30092157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Dynamics of bone biochemical markers in nephrotic children treated with prednisone and metabolites of vitamin D].
    Wojnar J; Roszkowska-Blaim M; Pańczyk-Tomaszewska M
    Przegl Lek; 2007; 64(9):552-8. PubMed ID: 18510075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin D status is insufficient in the majority of children at diagnosis of nephrotic syndrome.
    Nielsen CA; Jensen JE; Cortes D
    Dan Med J; 2015 Feb; 62(2):. PubMed ID: 25634505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone modulating factors in nephrotic children with normal glomerular filtration rate.
    Freundlich M; Bourgoignie JJ; Zilleruelo G; Jacob AI; Canterbury JM; Strauss J
    Pediatrics; 1985 Aug; 76(2):280-5. PubMed ID: 3839579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D in nephrotic syndrome remission: a case-control study.
    Banerjee S; Basu S; Sengupta J
    Pediatr Nephrol; 2013 Oct; 28(10):1983-9. PubMed ID: 23708762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin D and parathyroid hormone status in children with the nephrotic syndrome and chronic mild glomerulonephritis.
    Chesney RW; Hamstra A; Rose P; DeLuca HF
    Int J Pediatr Nephrol; 1984 Mar; 5(1):1-4. PubMed ID: 6715110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of vitamin D and calcium supplementation in pediatric steroid-sensitive nephrotic syndrome.
    Banerjee S; Basu S; Sen A; Sengupta J
    Pediatr Nephrol; 2017 Nov; 32(11):2063-2070. PubMed ID: 28725977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioavailable vitamin D levels are reduced and correlate with bone mineral density and markers of mineral metabolism in adults with nephrotic syndrome.
    Aggarwal A; Yadav AK; Ramachandran R; Kumar V; Kumar V; Sachdeva N; Khandelwal N; Jha V
    Nephrology (Carlton); 2016 Jun; 21(6):483-9. PubMed ID: 26428957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a role for 1,25-dihydroxyvitamin D3 in the pathogenesis and treatment of X-linked hypophosphatemic rickets and osteomalacia.
    Drezner MK; Lyles KW; Haussler MR; Harrelson JM
    J Clin Invest; 1980 Nov; 66(5):1020-32. PubMed ID: 6253520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperphosphatemia is prevalent among children with nephrotic syndrome and normal renal function.
    Feinstein S; Becker-Cohen R; Rinat C; Frishberg Y
    Pediatr Nephrol; 2006 Oct; 21(10):1406-12. PubMed ID: 16897004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin D metabolites and calcium metabolism in patients with nephrotic syndrome and normal renal function.
    Goldstein DA; Haldimann B; Sherman D; Norman AW; Massry SG
    J Clin Endocrinol Metab; 1981 Jan; 52(1):116-21. PubMed ID: 6969729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pathogenesis of renal osteodystrophy: role of vitamin D, aluminium, parathyroid hormone, calcium and phosphorus.
    Dunstan CR; Hills E; Norman AW; Bishop JE; Mayer E; Wong SY; Johnson JR; George CR; Collett P; Kalowski S
    Q J Med; 1985 May; 55(217):127-44. PubMed ID: 4001311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of metabolic bone disease in adult patients with the nephrotic syndrome and normal renal function.
    Korkor A; Schwartz J; Bergfeld M; Teitelbaum S; Avioli L; Klahr S; Slatopolsky E
    J Clin Endocrinol Metab; 1983 Mar; 56(3):496-500. PubMed ID: 6822651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin D metabolites in childhood nephrotic syndrome.
    Grymonprez A; Proesmans W; Van Dyck M; Jans I; Goos G; Bouillon R
    Pediatr Nephrol; 1995 Jun; 9(3):278-81. PubMed ID: 7632510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium and vitamin D metabolism in children with nephrotic syndrome.
    Freundlich M; Bourgoignie JJ; Zilleruelo G; Abitbol C; Canterbury JM; Strauss J
    J Pediatr; 1986 Mar; 108(3):383-7. PubMed ID: 3485195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycophenolate mofetil therapy for steroid-resistant IgA nephropathy with the nephrotic syndrome in children.
    Kang Z; Li Z; Duan C; Wu T; Xun M; Ding Y; Zhang Y; Zhang L; Yin Y
    Pediatr Nephrol; 2015 Jul; 30(7):1121-9. PubMed ID: 25773534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone histology and calcium metabolism in patients with nephrotic syndrome and normal or reduced renal function.
    Tessitore N; Bonucci E; D'Angelo A; Lund B; Corgnati A; Lund B; Valvo E; Lupo A; Loschiavo C; Fabris A
    Nephron; 1984; 37(3):153-9. PubMed ID: 6738766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.